You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Nevi

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study of the Nevisense Device to Assess Atypical Skin Lesions

Recruiting
  • Nevus
  • +3 more
  • Nevisense electrical impedance spectroscopy
  • Basking Ridge, New Jersey
  • +2 more
Jan 10, 2022

Pediatric Melanocytic Nevi Regarding Pattern and Diameter

Completed
  • Nevus, Pigmented
  • Videodermoscopy
  • Istanbul, Istanbul/Fatih, Turkey
    Istanbul Teaching and Research Hospital
Jul 18, 2022

Defining Genetic Basis for Development of Primary Pigmented

Completed
  • Cushing's Syndrome
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 18, 2023

Dysplastic Nevus Syndrome Trial in Chicago (20% betulinic acid ointment, BA)

Withdrawn
  • Dysplastic Nevus Syndrome
  • 20% betulinic acid ointment
  • BA
  • Chicago, Illinois
    University of Illinois at Chicago Medical Center
Jun 25, 2021

Clinical, Laboratory, and Epidemiologic Characterization of

Recruiting
  • Melanoma
  • Dysplastic Nevus Syndrome
    • Bethesda, Maryland
    • +1 more
    Jan 18, 2023

    Melanoma Advanced Imaging Dermatoscope (mAID)

    Recruiting
    • Melanoma
      • Irvine, California
      • +4 more
      May 10, 2022

      Genetic Basis of Melanocytic Nevi

      Recruiting
      • Melanocytic Nevi
      • Collecting Nevi
      • Sacramento, California
        University of California-Davis, Department of Dermatology
      Nov 23, 2022

      Cutaneous Melanocytic Tumor, Large Cutaneous Melanocytic Nevi, Neurocutaneous Melanocytosis Trial in New York

      Recruiting
      • Cutaneous Melanocytic Neoplasm
      • +2 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Feb 9, 2022

        Pregnancy-related Changes in Melanocytic Nevi

        Completed
        • Melanocytic Nevi (MN)
        • standard-of-care clinical skin examination
        • +2 more
        • Basel, Switzerland
          University Hospital Basel, Department of Dermatology
        May 17, 2022

        Congenital Melanocytic Nevus Trial (Squaric Acid Dibutyl Ester, Ethanol Solution)

        Not yet recruiting
        • Congenital Melanocytic Nevus
        • Squaric Acid Dibutyl Ester
        • Ethanol Solution
        • (no location specified)
        Oct 26, 2021

        BioMEL- Diagnostic and Prognostic Factors in Melanoma.

        Recruiting
        • Melanoma
        • +5 more
        • Imaging
        • Helsingborg, Skane, Sweden
        • +3 more
        Sep 1, 2022

        Direct-to-patient Teledermatology and Computer-assisted

        Recruiting
        • New Patient Use of Teledermatology Mobile App
        • New patient teledermatology visit
        • San Francisco, California
          San Francisco VA Medical Center, San Francisco, CA
        May 5, 2022

        Smartphone Application to Detect Skin Lesions

        Active, not recruiting
        • Skin Lesion
        • Photos
        • Chicago, Illinois
          Northwestern University Feinberg School of Medicine
        Nov 9, 2021

        Family Study of Melanoma in Italy

        Completed
        • Melanoma
        • +2 more
          • Cessana, Italy
          • +6 more
          Jun 30, 2020

          Nevi and Melanomas Trial in Aurora (UV Counseling, UV Photo, Biological Sample)

          Recruiting
          • Nevi and Melanomas
          • UV Counseling
          • +2 more
          • Aurora, Colorado
            University of Colorado
          Apr 4, 2022

          Epidermal Nevi, Nevus Sebaceus Trial in Redwood City (NFX-179 Gel 1.50%)

          Not yet recruiting
          • Epidermal Nevi
          • Nevus Sebaceus
          • NFX-179 Gel 1.50%
          • Redwood City, California
            Stanford University
          Mar 22, 2022

          Ambiguous Melanocytic Proliferation

          Not yet recruiting
          • Melanoma
          • Immunomarkers
          • Strasbourg, France
            Les Hôpitaux Universitaires de Strasbourg
          Oct 11, 2021

          Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

          Active, not recruiting
          Has Results
          • Multiple Myeloma
          • Ixazomib
          • +2 more
          • Duarte, California
          • +9 more
          Jan 11, 2023

          Resolution Fullfield Optical Coherence Tomography: Establishment

          Active, not recruiting
          • Healthy Skin
          • Nevus
          • ApolloVue® S100 Image System
          • Taipei city, Beitou District, Taiwan
            Taipei Veterans General Hospital
          Sep 25, 2021

          Frequency and Clinical Phenotype of BAP1 Hereditary

          Recruiting
          • Uveal Melanoma
          • +7 more
            • Columbus, Ohio
              The Ohio State University Wexner Medical Center
            Jul 6, 2022

            Sleep Disorders and Quality of Life in Multiple Sclerosis

            Not yet recruiting
            • Sleep Disorder
              • (no location specified)
              Aug 24, 2023

              Melanoma Trial in Memphis

              Recruiting
              • Melanoma
                • Memphis, Tennessee
                  St. Jude Children's Research Hospital
                Aug 19, 2021

                BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma

                Active, not recruiting
                • Choroidal Nevi, Uveal Melanoma
                  • Houston, Texas
                  • +2 more
                  Mar 24, 2021

                  Project in First-degree Relatives of Myeloma Patient - The

                  Recruiting
                  • Multiple Myeloma
                  • Monoclonal Gammopathy of Undetermined Significance
                  • Sample of Blood
                  • Shanghai, Shanghai, China
                    Zhongshan Hospital，Fudan University
                  Jul 31, 2023

                  Multiple Myeloma Trial (AZD0305)

                  Not yet recruiting
                  • Multiple Myeloma
                  • (no location specified)
                  Oct 24, 2023